Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 08:34 am Unchanged | 2025-03-31 | 13G | Sera Prognostics, Inc. SERA | Vivo Capital IX, LLC | 1,650,440 4.500% | 0 (Unchanged) | Filing History |
| 2025-03-19 3:00 pm Purchase | 2025-03-17 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital IX, LLC | 4,539,456 6.300% | 4,539,456 (New Position) | Filing History |
| 2024-11-14 6:59 pm Purchase | 2024-09-30 | 13G | Instil Bio, Inc. TIL | Vivo Capital IX, LLC | 585,485 9.000% | 585,485 (New Position) | Filing History |
| 2024-04-02 5:44 pm Unchanged | 2024-03-28 | 13D | Genetron Holdings Limited GTH | Vivo Capital IX, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:03 pm Sale | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 894,826 2.700% | -1,367,374 (-60.44%) | Filing History |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Sera Prognostics, Inc. SERA | Vivo Capital IX, LLC | 1,650,440 5.400% | -205,571 (-11.08%) | Filing History |
| 2023-10-19 4:30 pm Purchase | 2023-10-11 | 13D | Genetron Holdings Limited GTH | Vivo Capital IX, LLC | 9,524,767 6.000% | 9,524,767 (New Position) | Filing History |
| 2023-02-13 5:54 pm Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Vivo Capital IX, LLC | 0 0.000% | -5,202,348 (Position Closed) | Filing History |
| 2023-02-13 5:52 pm Sale | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 2,262,200 8.500% | -725,131 (-24.27%) | Filing History |
| 2023-02-13 5:51 pm Purchase | 2022-12-31 | 13G | Genetron Holdings Limited GTH | Vivo Capital IX, LLC | 9,524,767 6.300% | 9,524,767 (New Position) | Filing History |
| 2023-02-13 5:48 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 3,761,947 3.100% | -5,647,104 (-60.02%) | Filing History |
| 2023-02-13 5:44 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Capital IX, LLC | 772,068 2.300% | 772,068 (New Position) | Filing History |
| 2022-07-05 5:06 pm Sale | 2022-07-01 | 13G | Sierra Oncology, Inc. SRRA | Vivo Capital IX, LLC | 0 0.000% | -1,935,853 (Position Closed) | Filing History |
| 2022-02-11 5:27 pm Sale | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Vivo Capital IX, LLC | 326,888 1.800% | -326,891 (-50.00%) | Filing History |
| 2022-02-11 5:26 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 9,409,051 7.800% | 448,755 (+5.01%) | Filing History |
| 2022-02-11 5:25 pm Purchase | 2021-12-31 | 13G | IVERIC bio, Inc. ISEE | Vivo Capital IX, LLC | 5,202,348 4.500% | 5,202,348 (New Position) | Filing History |
| 2022-02-11 5:23 pm Purchase | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX, LLC | 624,902 1.400% | 624,902 (New Position) | Filing History |
| 2022-02-11 5:22 pm Purchase | 2022-01-31 | 13G | Sierra Oncology, Inc. SRRA | Vivo Capital IX, LLC | 2,735,852 14.700% | 2,735,852 (New Position) | Filing History |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 2,987,331 14.400% | -257,704 (-7.94%) | Filing History |
| 2021-11-12 4:30 pm Purchase | 2021-11-09 | 13G | IO Biotech, Inc. IOBT | Vivo Capital IX, LLC | 3,015,545 10.500% | 3,015,545 (New Position) | Filing History |